Fimasartan versus perindopril with and without diuretics in the treatment of elderly patients with essential hypertension (Fimasartan in the Senior Subjects (FITNESS)): study protocol for a randomized controlled trial

BACKGROUND: Hypertension is an important risk factor for cardiovascular disease, even in the elderly. Fimasartan is a new non-peptide angiotensin II receptor blocker with a selective type I receptor blocking effect. The objective of this study is to confirm the safety and the non-inferiority of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Min-gu, Kim, Kwang-il, Ihm, Sang Hyun, Rhee, Moo-Yong, Sohn, Il Suk, Lee, Hae-Young, Park, Sungha, Jeon, Eun-Seok, Song, Jong-Min, Pyun, Wook Bum, Sung, Ki-Chul, Kim, Moo Hyun, Kim, Sang-Hyun, Kim, Seok-Yeon, Kim, Shin-Jae, Kim, Eung Ju, Shin, Jinho, Lee, Sung Yun, Chun, Kook-Jin, Jeong, Jin-Ok, Chae, Shung Chull, Yoo, Ki Dong, Choi, Young Jin, Park, Yong Hwan, Kim, Cheol-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604456/
https://www.ncbi.nlm.nih.gov/pubmed/31262348
http://dx.doi.org/10.1186/s13063-019-3466-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604456/
https://www.ncbi.nlm.nih.gov/pubmed/31262348
http://dx.doi.org/10.1186/s13063-019-3466-5

Ejemplares similares